Corbus Pharmaceuticals Revenue and Competitors

Claim your profile

Norwood, MA USA

Location

$196.9M

Total Funding

Cannabis

Industry

Estimated Revenue & Valuation

  • Corbus Pharmaceuticals's estimated annual revenue is currently $4.8M per year.(i)
  • Corbus Pharmaceuticals received $27.2M in venture funding in March 2017.
  • Corbus Pharmaceuticals's estimated revenue per employee is $70,882
  • Corbus Pharmaceuticals's total funding is $196.9M.

Employee Data

  • Corbus Pharmaceuticals has 68 Employees.(i)
  • Corbus Pharmaceuticals grew their employee count by -35% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$27M1008%N/AN/A
#2
$323.6M648-33%$1.2BN/A
#3
$29.4M10918%N/AN/A
#4
$20.8M774%N/AN/A
#5
$4.8M68-35%$196.9MN/A
#6
$23.8M8814%N/AN/A
#7
$16.8M698%N/AN/A
#8
$26.2M9741%N/AN/A
#9
$30.5M11318%N/AN/A
#10
$15.6M6423%N/AN/A

Corbus Pharmaceuticals (NASDAQ: CRBP) is a Phase 3, clinical-stage pharmaceutical company focused on advancing the development and commercialization of novel therapies to treat rare, chronic, and serious inflammatory and fibrotic diseases. The Company's lead product candidate, lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Corbus Pharma was named one of the Best Places To Work by Boston Business Journal in 2017. Our people are high-achievers, innovative, creative and, above all else, passionate about what we do in systemic sclerosis, cystic fibrosis, dermatomyositis and systemic lupus eythematosus.

keywords:Biotechnology,Healthcare,Pharmaceuticals

$196.9M

Total Funding

68

Number of Employees

$4.8M

Revenue (est)

-35%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Corbus Pharmaceuticals News

2022-04-17 - Corbus Pharmaceuticals Holdings Inc. stock falls Friday, still outperforms market MarketWatch

Corbus Pharmaceuticals Holdings Inc. stock falls Friday, still outperforms market MarketWatch

2022-04-17 - Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors despite losses on the day MarketWatch

Corbus Pharmaceuticals Holdings Inc. stock outperforms competitors despite losses on the day MarketWatch

2022-04-17 - Corbus Pharmaceuticals Holdings Inc. stock outperforms market on strong trading day MarketWatch

Corbus Pharmaceuticals Holdings Inc. stock outperforms market on strong trading day MarketWatch

2020-08-24 - CORBUS PHARMACEUTICALS HOLDINGS, INC. Corbus Pharmaceuticals : Conference Call Transcript Q3 2018

Corbus Pharmaceuticals Holdings, Inc. Quarterly Update Conference Call and Webcast November 8, 2018 Operator: Greetings and welcome to the Corbus Pharmaceuticals Quarterly Update Conference Call and Webcast. At this time, all participants are on a listen only mode. A Question and Answer sessi ...

2020-08-13 - CORBUS PHARMACEUTICALS HOLDINGS, INC. Corbus Pharmaceuticals : Conference Call Transcript Q2 2020

Corbus Pharmaceuticals Holdings Second Quarter Earnings Conference Call August 6, 2020 Page 1 of 14 Operator: Hello and welcome to the Corbus Pharmaceuticals Second Quarter August 6, 2020 Earnings Conference Call. As a reminder, all participants are in a listen-only mode. If anyone should re ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$12.9M703%N/A
#2
$17.2M706%N/A
#3
$17.5M76245%N/A
#4
$3.5M771%N/A
#5
$12.3M78-1%N/A

Corbus Pharmaceuticals Funding

DateAmountRoundLead InvestorsReference
2014-04-29$6.3MUndisclosedArticle
2014-06-04$10.3MUndisclosedAegis Capital CorpArticle
2014-12-12$12.7MUndisclosedArticle
2016-06-13$14.9MUndisclosedArticle
2017-03-01$27.2MUndisclosedArticle